Company: MIRM
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001759425-25-000032
Chunk: 333

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-05-07
Form: 10-Q
Item: Part I, Item 1
Chunk 333
---
Mirum Pharmaceuticals, Inc.

Condensed Consolidated Statements of Operations

(Unaudited) 

(In thousands, except share and per share data)

 Three Months Ended March 31, 20252024Revenue:Product sales, net$111,585 $68,917 License and other revenue— 305 Total revenue111,585 69,222 Operating expenses:Cost of sales23,018 17,830 Research and development46,044 32,222 Selling, general and administrative57,706 45,638 Total operating expenses126,768 95,690 Loss from operations(15,183)(26,468)Other income (expense):Interest income3,023 3,633 Interest expense(3,596)(3,577)Other income, net2,108 1,757 Net loss before provision for income taxes(13,648)(24,655)Provision for income taxes1,029 624 Net loss$(14,677)$(25,279)Net loss per share, basic and diluted$(0.30)$(0.54)Weighted-average shares of common stock outstanding, basic and diluted48,889,05846,927,550

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

Table of Contents

Mirum Pharmaceuticals, Inc.

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited)

(In thousands)

 Three Months Ended March 31, 20252024Net loss$(14,677)$(25,279)Other comprehensive income (loss):Unrealized loss on available-for-sale investments(23)— Cumulative translation adjustments138 (1,657)Comprehensive loss$(14,562)$(26,936)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Mirum Pharmaceuticals, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

(In thousands, except share amounts)

 Common StockAdditionalPaid-InCapitalAccumulatedDeficitAccumulatedOtherComprehensive Income (Loss) TotalStockholders’Equity  SharesAmountBalance as of December 31, 2024 48,338,096$5 $870,189 $(644,181)$(373)$225,640 Issuance of common stock in connection with equity award plans1,112,939— 6,359 — — 6,